Atossa Therapeutics
ATOS
#10092
Rank
โ‚น3.74 B
Marketcap
โ‚น435.43
Share price
1.79%
Change (1 day)
457.97%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น23.92. In 2024 the company made an earnings per share (EPS) of -โ‚น19.14 an increase over its 2023 EPS that were of -โ‚น22.97.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5212.45%
2024-โ‚น19.14-16.67%
2023-โ‚น22.9714.29%
2022-โ‚น20.1016.67%
2021-โ‚น17.23-90.86%
2020-โ‚น188.53-2.96%
2019-โ‚น194.27-63.09%
2018-โ‚น526.34-49.63%
2017-โ‚น1,045-57.87%
2016-โ‚น2,481-74.01%
2015-โ‚น9,543-9.18%
2014-โ‚น10,508-12.86%
2013-โ‚น12,05870.73%
2012-โ‚น7,06334.08%
2011-โ‚น5,267263.47%
2010-โ‚น1,449

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น836.05-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น877.55-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,087-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น59.33 148.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น20.10-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA